The early life microbiota protects neonatal mice from pathological small intestinal epithelial cell shedding

Abstract

The early life gut microbiota plays a crucial role in regulating and maintaining the intestinal barrier, with disturbances in these communities linked to dysregulated renewal and replenishment of intestinal epithelial cells. Here we sought to determine pathological cell shedding outcomes throughout the postnatal developmental period, and which host and microbial factors mediate these responses. Surprisingly, neonatal mice (Day 14 and 21) were highly refractory to induction of cell shedding after intraperitoneal administration of liposaccharide (LPS), with Day 29 mice showing strong pathological responses, more similar to those observed in adult mice. These differential responses were not linked to defects in the cellular mechanisms and pathways known to regulate cell shedding responses. When we profiled microbiota and metabolites, we observed significant alterations. Neonatal mice had high relative abundances of Streptococcus, Escherichia, and Enterococcus and increased primary bile acids. In contrast, older mice were dominated by Candidatus Arthromitus, Alistipes, and Lachnoclostridium, and had increased concentrations of SCFAs and methyamines. Antibiotic treatment of neonates restored LPS-induced small intestinal cell shedding, whereas adult fecal microbiota transplant alone had no effect.Our findings further support the importance of the early life window for microbiotaepithelial interactions in the presence of inflammatory stimuli and highlights areas for further investigation. K E Y W O R D S antibiotics, cell shedding, early life, fecal microbiota transplant, inflammation, intestinal epithelium, metabolites, microbiota 7076 | HUGHES Et al.

Bacillus coagulans protect against Salmonella enteritidis-induced intestinal mucosal damage in young chickens by inducing the differentiation of goblet cells

“…The intestinal mucosal barrier plays a key role in separating harmful substances such as bacteria and toxins from the internal milieu ( Turner, 2009 ). Microbiota-epithelial interactions in the early life window profoundly affect the establishment of intestinal barrier function and host immune system ( Hughes et al, 2020 ; Yeşilyurt et al, 2021 ). Moreover, the early colonization of beneficial bacteria could promote the maturation of gut microbiota and competitive exclusion of enteric pathogens ( Pickard et al, 2017 ).…”

Host Age Prediction from Fecal Microbiota Composition in Male C57BL/6J Mice

“…Longitudinal studies are rarely performed unlike cross-sectional studies as the latter are more feasible to conduct. Cross-sectional studies of the murine gut microbiome are generally focused on the early or later years of the murine life ( 2 , 12 , 13 ). One such study examined the gut microbiomes of “young” (24-week-old), “middle-age” (84-week-old), and “very old” (122-week-old) female C57BL/6J mice with observed major shifts in nine of the most abundant bacterial families and functional genes that could affect host health ( 2 ).…”

Synergistic Protective Effect of Konjac Mannan Oligosaccharides and Bacillus subtilis on Intestinal Epithelial Barrier Dysfunction in Caco-2 Cell Model and Mice Model of Lipopolysaccharide Stimulation

“…LPS not only causes inflammation damage, but also induces oxidative stress (10), causing damage to the intestinal structure and function (11). LPS is often used to induce intestinal epithelial barrier dysfunction in a Caco-2 cell model (12) and a pathological mouse model (13).…”